| For: | Gao Z, Wang XY, Song T, Shen ZG, Wang XY, Wu SK, Jin X. Targeted therapy combined with immunotherapy vs trifluridine/tipiracil with bevacizumab as late-line therapy in metastatic colorectal cancer. World J Gastroenterol 2025; 31(29): 109947 [PMID: 40809924 DOI: 10.3748/wjg.v31.i29.109947] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v31/i29/109947.htm |
| Number | Citing Articles |
| 1 |
Xiao-Yuan Chu, Yi-Tian Chen, Tian-Long Zhang, Ying Zhao, Yu-He Zhou, Yi Zhao, Ping Li, Jun Pan. Efficacy and safety of fruquintinib plus sintilimab in third-line treatment of metastatic colorectal cancer: A single-center experience. World Journal of Gastrointestinal Oncology 2026; 18(6): 117101 doi: 10.4251/wjgo.v18.i6.117101
|
| 2 |
Gang Li, Wenzhong Zhang, Jie Wang, Baiying Xu, Yongbing Wang. Prognostic role of statins in colorectal cancer: a systematic review and meta-analysis. Frontiers in Oncology 2026; 16 doi: 10.3389/fonc.2026.1763323
|
| 3 |
Jingjing Liu, Xiaojing Xu, Gengyun Miao, Shengxiang Rao, Mengsu Zeng, Tianshu Liu, Liheng Liu. A clinico-radiological model integrating baseline CT-derived body composition to predict prognosis in immunotherapy-treated metastatic colorectal cancer. European Journal of Radiology 2026; 203 doi: 10.1016/j.ejrad.2026.113000
|